Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population-based Genetic Testing for Precision Prevention.

Cancer prevention research (Philadelphia, Pa.) - 1 Aug 2020

Evans Olivia, Manchanda Ranjit

Abstract excerpt

Global interest in genetic testing for cancer susceptibility genes (CSG) has surged with falling costs, increasing awareness, and celebrity endorsement. Current access to genetic testing is based on clinical criteria/risk model assessment which uses family history as a surrogate. However, this approach is fraught with inequality, massive underutilization, and misses 50% CSG carriers. This reflects huge missed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Counseling
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Patient Education as Topic

Share to Precision Medicine

Share to Risk Assessment

Source

Identifiers

PMID: 32409595
DOI: 10.1158/1940-6207.CAPR-20-0002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population-based Genetic Testing for Precision Prevention.PMID 32409595Read ↗

Population-based genetic testing for Women's cancer prevention.Semantic proximity Read ↗

Genetic screening for gynecological cancer: where are we heading?Semantic proximity Read ↗

Population Based Testing for Primary Prevention: A Systematic ReviewSemantic proximity Read ↗

Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.Semantic proximity Read ↗

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.Semantic proximity Read ↗

Population‐based genetic testing for cancer susceptibility genes: quo vadis?Semantic proximity Read ↗

Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.Semantic proximity Read ↗

Genetic screening.Semantic proximity Read ↗

Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time.Semantic proximity Read ↗

Population-based BRCA1/BRCA2 screening in Ashkenazi Jews: a call for evidence.Semantic proximity Read ↗

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.Semantic proximity Read ↗

Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.